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THE THESIS EXPLAINED 
Spermatogenesis in mammals is a high efficient process which 
results in a daily production of millions of mature spermatozoa 
(Johnson et al., 1980) and relies on a stem cell pool of 
spermatogonial stem cells (SSCs).  
Sertoli cell, the unique somatic cell within the seminiferous tubules 
of testis, constitutes a specialized microenvironment called “SSCs 
niche” and directly controls SSCs behaviour. Sertoli cells secrete 
the niche factor GDNF, which acts on stem cells and is known to be 
crucial for their survival and self-renewal, in vitro and in vivo. On 
the other side, the key to commitment for SSCs is represented by 
retinoic acid (RA), the active metabolite of vitamin A, which is 
released within the testicular microenvironment. GDNF and RA are 
both essential for spermatogenesis, in fact in the absence both of 
GDNF or RA, the spermatogenic process is blocked (Meng et al., 
2000; Wolbach & Howe, 1925).  
In this work we demonstrated that RA negatively regulates GDNF 
in immature murine Sertoli cells, affecting both mRNA and secreted 
protein, confirming previous evidence in literature (Hasegawa et al., 
2013). RARα is the nuclear receptor involved in this regulation 
acting through a novel-identified  Retinoic Acid Responsive 
Element (RARE) on Gdnf murine promoter. Data obtained with 
HDACi suggested that the underlying molecular mechanism 
involved an epigenetic repression mediated by HDAC enzymes. 
These results were confirmed by ChIP-qPCR experiments, that 
indicated that Gdnf promoter undergoes a de-acetylation after RA 
treatment. We then focused our attention on adult mouse, where 
gdnf regulation is conserved. Finally, we investigated this regulation 
in human testis, and we found that in our culture conditions testis 
tissue positively responds to RA stimulation while RA effect on 
gdnf expression is heterogeneous.  
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INTRODUCTION  
1. Overview on Spermatogenesis  
  
In mammals, spermatogenesis is a complex, efficient and highly 
regulated process that starts from puberty and guarantees a 
continuous formation of spermatozoa, the male gametes responsible 
for the transmission of the genetic makeup to subsequent 
generations.  
Spermatogenesis takes place in the testis. Testes are two oval-
shaped organs covered by a fibrous multi-layered tunica, properly 
named vasculosa, albuginea and vaginalis. Within the testis, septa 
of connective tissue create lobules that hold highly convoluted 
seminiferous tubules. This last are tubular structures enclosed by a 
thick basal lamina and smooth muscle cells, that hold germ cells 
and somatic Sertoli cells. 
The continuous production of mature spermatozoa depends on the 
activity of an adult, rare, unipotent stem cell: the spermatogonial 
stem cell (SSC), that in mice constitutes only 0.03% of total germ 
cells (Tegelenbosch & de Rooij, 1993).  
The complex process of spermatogenesis can be divided into three 
phases: proliferative phase, meiotic phase and spermiogenesis, that 
will be described below.  
In the first phase, cells in the spermatogonial compartment begin a 
series of mitotic divisions aimed at the production of new 
spermatogonia and at the replacement of SSCs that periodically get 
lost. In the mouse, the spermatogonial compartment has been 
traditionally divided into two categories: the undifferentiated (which 
contains the SSCs) and the differentiating spermatogonia, both 
located on the basal membrane of the seminiferous tubule. The first 
category include the A-single (As); A-pair (Apr) which are two 
daughter cells remained connected by an intracellular bridge due to 
an incomplete cytodieresis; A-aligned (Aal) spermatogonia which 
are chains of 4, 8, 16 or occasionaly 32 clone cells connected by 
intercellular bridges.  
Differentiating spermatogonia comprise A1, A2, A3, A4, 
Intermediate and B spermatogonia. All these cells are characterized 
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by the expression of KIT, SOHLH1 and SOHLH2 (Barrios et al., 
2012; Suzuki et al., 2012). The last mitotic division of the B 
spermatogonia generates the preleptotene spermatocytes, the cells 
entering in meiosis.  
Human spermatogonial subpopulation is less characterized with  
respect to the murine counterpart. It can be divided into three 
categories: A dark (Ad), A pale (Ap) and B spermatogonia. Ad and 
Ap can be distinguished on the basis of nuclear morphology and 
intensity of staining with hematoxylin (Clermont & Leblond, 1959; 
Clermont & Antar, 1973; Clermont, 1966). Ad and Ap  
spermatogonia are considered as the counterpart for murine 
undifferentiated spermatogonia, while type B represents the 
differentiating cells, that divide to produce primary spermatocytes, 
secondary spermatocytes and spermatids (Boitani et al., 2016). It 
was commonly accepted that Ad constitute a pool of quiescent 
spermatogonia which can give rise to Ap when needed, and were 
thought to be the human „true‟ SSCs (Amann, 2008; Boitani et al., 
2016).  Recently, a new classification of the human spermatogonial 
subsets based on spermatogonial kinetics and marker expression 
have questioned the classical view of Ad and Ap (Di Persio et al., 
2017). Clearly, the identification of the human SSCs deserve further 
studies.  
Spermatogonia differentiate into primary spermatocytes and enter 
the second phase of spermatogenesis, the meiotic phase. The first 
meiotic division is characterized by a long prophase, including 
leptotene, zygotene, pachytene and diplotene spermatocytes. 
Diplotene spermatocytes undergo two rapid subsequent divisions 
producing four haploid round spermatids from each germ cell, 
which undergo the spermiogenesis phase. In this last phase haploid 
spermatids get mature and differentiate into spermatozoa, cells 
characterized by elongated shape, compact nucleus and flagellum 
At the end, spermatozoa can be released into the lumen of the 
seminiferous tubule in a controlled process named spermiation.  
During their maturation, germ cells gradually move in an organized 
and coordinated movement from the basement membrane towards 
the lumen of the tubule, where spermatozoa will be released. In the 
mouse, the time required to form a sperm from a A1 spermatogonia, 
hence the total duration of spermatogenesis, is 35 days, while in 
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human is approximately 74 days (Heller & Clermont, 1963) (Heller 
& Clermont, 1964). 
In mammals, within the seminiferous tubule it is possible to 
recognize different cellular associations called stages of the 
seminiferous epithelium, that succeed each other in time in any 
given area (Leblond & Clermont, 1952). “A complete series of the 
successive cell associations found along a seminiferous tubule” was 
described by Clermont as “the wave of the seminiferous 
epithelium”, while “a complete series of the successive cellular 
associations appearing in any one given area of the seminiferous 
tubule” is known as the cycle of the seminiferous epithelium 
(Leblond & Clermont, 1952).  
In mouse, the time required for a stage to reappear in the same area 
is 8,6 days (Oakberg, 1956 b) while in human the duration of one 
cycle of the seminiferous epithelium is 16 days (Clermont, 1963). 
This highly complex tissue organization guarantees a continuous 
release of mature spermatozoa into the epididymis, that occurs in 
each area once every 8,6 days in mouse (Oakberg, 1956 a) every 16 
days in humans (Clermont, 1963).  
Spermatogenesis in rodents has been widely characterized and its 
study represents a model for the comprehension of the human 
spermatogenesis. In mouse, twelve different cell associations or 
stages have been described, indicated by Roman numerals I-XII 
(Oakberg, 1956 a). In human, for a long time six stages have been 
defined. More recently, in order  to better parallel human and 
murine cycle of the seminiferous epithelium (Amann, 2008), twelve 
stages have been characterized also in human, based on spermatids 
acrosome development (Muciaccia et al., 2013). Spermatids, cells 
that undergo the most prominent cytological changes among 
cellular elements of the tubule (Clermont, 1960), make stages easily 
recognizable through the developmental step of their acrosome 
(Clermont & Leblond, 1955).  
However, while in the mouse the twelve stages are distributed in a 
linear sequence as small segments of the seminiferous tubule, in 
human, a tubule cross-section typically contains 2-4 stages. So it 
was proposed that the human cellular associations are organized as 
“intertwined helical bands” along the seminiferous tubules (Schulze 
& Rehder, 1984), and this explains why the isolation of staged 
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seminiferous tubules based on transillumination is possible for 
rodents seminiferous epithelium  but not for the human (Parvinen et 
al., 1972). 
Spermatogenesis is controlled by local molecules acting in 
autocrine or paracrine fashion, and by circulating hormones of the 
hypothalamic–pituitary-gonadal axis, through an endocrine level. 
Hypothalamus releases the gonadotropin releasing hormone GnRH, 
that in turn stimulates adenohypophysis to secrete follicle 
stimulating hormone FSH and luteinizing hormone LH. FSH 
hormone binds to its receptor FSHR on Sertoli cells, regulating the 
gene expression to support spermatogenesis (Walker & Cheng, 
2005). The FSH signaling also promotes the production of Inhibin 
B by Sertoli cells, which acts as a negative feedback on the 
production of FSH (de Kretser et al., 2001). 
LH on the contrary stimulates Leydig cells to produce testosterone 
which in turn acts as a negative feedback on the pituitary gland to 
block LH production (Ewing, 1993).  
 
 
1.1   Sertoli cells and the niche for the SSCs  
 
Like other adult self-renewing tissues, the seminiferous epithelium 
function relies on stem cells, more precisely spermatogonial stem 
cells (SSCs), which are subject to various extrinsic signals provided 
by the "stem niche". The stem cell niche is the microenvironment in 
which stem cells reside, and which provides stimuli able to 
influence the fate decisions: self-renewal or differentiation. Stimuli 
include cellular, cell-cell and cell-matrix interactions, and signal 
molecules able to affect the transcriptional program (Voog & Jones, 
2010).  The SSCs niche is the space comprised by the basal lamina 
of seminiferous tubules and the somatic Sertoli cells, which 
establish a close contact with germ cells. Also peritubular myoid 
cells, Leydig cells, macrophages and nerves (Caires et al., 2010) 
may be contributors of the niche. Interestingly, some Authors 
reported that the majority of Aundiff were clustered in regions of the 
tubules close to a blood vessel, suggesting that blood vessels could 
PhD in Morphogenesis and Tissue Engineering 
11 
provide an adequate support to SSCs (Chiarini-Garcia & Russell, 
2001; Yoshida et al., 2007). 
However, it is well known that Sertoli cells are the main 
protagonists of the spermatogonial niche (de Rooij, 2017) (Figure 
1). Sertoli appears as a large, columnar, arborized “nurse” cell 
(Griswold, 1995) which interacts with a well-defined number of 
germ cells, that vary among species (Russell & Peterson, 1984).   
The most evident morphologic feature in Sertoli cell, used for 
cellular recognition, is its euchromatic nucleus and the large 
nucleolus inside it. Interestingly, the nuclear shape changes during 
the seminiferous epithelium cycle. 
Figure 1 Sertoli cell observed using light microscopy (LM), transmission electron 
microscopy (TEM) and immunofluorescence microscopy (IF) (França et al., 
2016) 
Most important markers for Sertoli cells are nuclear: SOX9 (SRY-
box containing gene 9) (Frojdman et al., 2000), androgen receptor 
(AR) (Sar et al., 1990), GATA-binding protein 1 (GATA1) (Viger 
et al., 1998); Wilms tumor protein-1 (WT1) (Sharpe et al., 2003; 
Wang et al., 2013); cyclin-dependent kinase inhibitor 1B (p27kip1) 
(Sharpe et al., 2003). 
Sertoli cells are the primary regulators of the sex determination: in 
the developing urogenital ridge, they establish the male sex of the 
gonad by expressing the Sex-determining Region Y (Sry) gene 
(Lovell-Badge, 1993) and by inhibiting the development of female 
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structures through the Anti-Müllerian Hormone (AMH) (Josso et 
al., 1993). Sertoli cells actively proliferate during the fetal 
development and keep proliferating in the prepubertal period. In 
men two proliferation peaks occur during the first three months of 
life and then during puberty (Cortes et al., 1987). Proliferation is 
regulated by many factors such as FSH and Thyroid hormone (TH), 
paracrine factors as TGFβ, androgens and autocrine factors like IL-
1 (Tarulli et al., 2012). However, at puberty Sertoli cells stop 
proliferating, undergo terminal differentiation and the established 
Sertoli cell number determines the testicular size (França et al., 
2000).  
Sertoli cells play an important structural role in the seminiferous 
tubule, dividing the basal compartment from the adluminal 
compartment of the seminiferous epithelium through the blood-
testicular barrier (BTB), which is a structure formed by Sertoli cells 
tight junctions and composed by occludin, claudins and junctional 
adhesion molecules (Mruk & Cheng, 2010). During the cycle of the 
seminiferous epithelium, this structure, following retinoic acid 
pulse, faces dramatic restructuring (Hasegawa & Saga, 2012) 
allowing the transit of preleptotene spermatocytes from the basal to 
the adluminal compartment of the seminiferous epithelium.  
In the basal compartment, Sertoli cells, with their cytoplasmic 
branches, embrace SSCs confining them in a highly isolated 
microenvironment enriched of factors secreted by Sertoli 
themselves, interstitial cells and molecules brought by the blood 
(Oatley & Brinster, 2012). The main factors controlling the balance 
between self-renewal and differentiation are: GDNF, FGF2, which 
increase the proliferation activity of SSCs and SCF, Activin A, 
CSF-1 and BMP4 that stimulate differentiation. Some of these 
factors are under hormonal control (Boitani et al., 2016). 
Another important function of Sertoli cell is its phagocytic activity,  
aimed at the clearance of residual body of leftover spermatid 
cytoplasm and apoptotic cells. The phagocytic activity  relies on 
class B scavenger receptor type I (SR-BI) of Sertoli cells and 
phosphatidylserine exposed at the membranes of target cells 
(Nakagawa et al., 2005).  
Sertoli cells are also key regulators of androgen production, in fact 
they control Leydig cell population in the neonatal (Rebourcet et 
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al., 2014) and adult testis (Rebourcet et al., 2014b). Since the 
Sertoli cells and the Leydig in the interstitial tissue do not establish 
a direct contact, it is possible that the action of the Sertoli on them 
is mediated by secreted factors, or indirectly through peritubular 
myoid cells (Rebourcet et al., 2014b). Interestingly, in humans, 
Sertoli cell number, as well as Leydig cell number and function, 
decreases with aging (Johnson et al., 1984). In this context, the 
reduction of Sertoli cell number in men could be at the base of 
testosterone decrease associated with aging (Rebourcet et al., 2014 
b).   
Sertoli cells make testis an immune privileged organ. In fact, their 
immuno-regulatory properties create a microenvironment that 
suppresses immune reactions against spermatocytes and spermatids, 
that normally express proteins not recognized by the immunological 
self-tolerance (O‟Rand & Romrell, 1977; Tung & Fritz, 1978). This 
action is exerted physically by the BTB that impinges the transit of 
leukocytes and molecules in the seminiferous epithelium and by the 
secretion of a variety of molecules such as apoptosis inhibitors, 
complement inhibitors and immunoregulatory factors like TGFβ1, 
CCL27, IDO and galectin-1 (Guazzone et al., 2009; Meinhardt & 
Hedger, 2011; Doyle et al., 2012).  
 
 
2. Glial Cell Line-Derived Neurotrophic  Factor (Gdnf)     
 
The glial cell line-derived neurotrophic factor (Gdnf) was 
originally isolated in rat embryo midbrain cultures and identified as 
a crucial factor for midbrain dopaminergic neurons survival 
(Schubert, 1974). GDNF,  is one of the four neurotrophic factors of 
the GDNF family (GFLs), together with neurturin (NRTN), 
persephin (PSPN), artemin (ARTN) (Takahashi, 2001). GFLs 
constitute a subgroup of the TGF-β superfamily, with whom they 
share conformational features, like the “cysteine knot” structure 
(Lin et al., 1993).  
The murine Gdnf gene is located on chromosome 15 and consists of 
about 27 kb. It consists of three exons interspersed with two introns 
of 4.1Kb and approximately 18.5Kb. In the mouse, the presence of 
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alternative intronic promoters that generate transcripts with different 
5'-UTR ends was then described (Tanaka et al., 2000a; Tanaka et 
al., 2000b; Tanaka et al., 2001). The organization of the human 
gene encoding GDNF is similar to the murine, and also in this case 
the transcripts undergo alternative splicing to the 5'UTR region, 
thus generating multiple isoforms in the 5'UTR region (Airavaara et 
al., 2011). 
GDNF is synthesized as 211 amino acid precursor protein, 
converted into the 134 amino acid active form and then secreted 
(Lin et al., 1993). Differently from TGF-β family members, GFLs, 
bind to the glycosylphosphatidylinositol (GPI)-anchored GDNF 
family receptor α, GFRα-1, on the membrane surface (Jing et al., 
1996; Treanor et al., 1996). This binding raises GDNF affinity for 
the co-receptor c-RET, a tyrosine kinase transmembrane receptor, 
so that the GDNF-RET-GFRα-1 complex triggers the intracellular 
cascade.  
 
 
2.1 Gdnf expression in the testis 
 
The comprehension of the in vivo function of GDNF in mammalian 
testis dates back to 2000 when Meng and colleagues created a 
murine model which overexpressed GDNF or carried one GDNF-
null allele in the testis (Meng et al., 2000). In the first case, 
transgenic mice exhibited an increased number of spermatogonial 
stem cells (SSCs) organized in clusters, that degenerated over time 
into non-metastatic tumours. On the contrary, mice holding a single 
functioning Gdnf allele showed a progressive depletion of stem 
cells reserve resulting in Sertoli-cell-only phenotype and long-term 
impaired spermatogenesis. These results suggested the requirement 
of an optimum range of GDNF concentration for SSCs self- renewal 
(Chen et al., 2014). Later, GDNF was shown to be a crucial 
molecule for the expansion of SSCs in vitro (Kanatsu-Shinohara et 
al., 2005; 2003; Kubota et al., 2004). 
Within the testis, the main source of GDNF is Sertoli cell (Trupp et 
al., 1995, Golden et al., 1999). More recently, peritubular myoid 
(PM) cells were found expressing GDNF in human and murine 
PhD in Morphogenesis and Tissue Engineering 
 
15 
 
testis (Spinnler et al., 2010, Chen et al., 2014). PM cells are  
smooth-muscle-like cells that surround the external basal lamina of 
seminiferous tubules and were traditionally thought related to 
structural support and contractility of seminiferous tubules. This 
finding raised the hypothesis that also PM cells could influence 
SSCs behaviour and could actively take part in the SSCs niche. 
GDNF responsive cells are As and Apr which mostly expressed the 
GFRα-1 receptor. GFRα-1 is expressed at lower levels also in Aal 
(Nakagawa et al., 2010; Grasso et al., 2012).   
In human testis, the source of GDNF comprises Sertoli cells 
(Davidoff et al., 2001) and myoid peritubular cells (Spinnler et al., 
2010, Chen et al., 2014; Chen et al., 2016). 
Both Apale and Adark spermatogonia express the GDNF receptor 
GFRα-1 (Grisanti et al., 2009), which in complex results expressed 
by 54 ± 8% of the cells in the spermatogonial compartment (Di 
Persio et al., 2017). 
The role of GDNF in human testis  is still poorly understood, even 
if a similar function to that in rodents has been hypothesized. In 
2012 the expression of GDNF mRNA and protein was analyzed in 
Sertoli cells from non obstructive azoospermia (NOA) patients, 
which are characterized by the loss of germ cells and impaired 
spermatogenesis. This study showed that NOA patients exhibited 
remarkably lower levels of GDNF mRNA and protein respect to the 
normal counterpart (Ma et al., 2013). The same conclusions were 
drawn by Singh and colleagues which analysed GDNF expression 
in Sertoli cells from Sertoli cell-only (SCO) patients (Singh et al., 
2017). They showed a 3,4 fold less production of GDNF and a 10 
fold reduction of GFR-1 expression in SCO testes compared to the 
normal. 
In target cells, GDNF downstream signalling leads to a wide gene 
expression modulation. In particular, by microarray analysis, 1124 
genes were found differentially modulated after GDNF exposure. 
Among these, N-Myc and L-Myc, as well as cyclins D3 and B were 
found up-regulated. On the contrary, cell cycle inhibitors p21, p19 
and p15 resulted down-regulated (Hofmann et al., 2005).  
GDNF also positively regulates a series of genes proved to be 
crucial to spermatogonial self-renewal, such as (Oatley et al., 2006; 
Oatley et al., 2007) Bcl6b (B cell CLL/lymphoma 6 member B), 
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Erm (Ets variant 5), Lhx1 (LIM homeobox 1). Moreover GDNF 
stimulates spermatogonia expression of its own receptor GFR-1 
(Grasso  et al., 2012) and Fibroblast Growth Factor 2 receptor, 
FGFR2, increasing the responsiveness to this molecule that in turn 
stimulates SSCs self-renewal (Hofmann et al., 2005).  
Although  Gdnf role as promoting SSCs self-renewal has been well 
established, a role in influencing SSCs differentiation was also 
hypothesized. In fact the activation of ERK1/2 in GFRα-1 positive 
spermatogonia, under the control of GDNF, prevents them from 
differentiation (Hasegawa et al., 2013). In the same direction are 
data from Ikami and colleagues, that discriminate spermatogonia in 
two subsets: GFRα-1+, that appeared to be resistant from the 
differentiating stimulus of retinoic acid, and the NGN3
+
 that 
showed a rapid tendency to differentiate into KIT
+
 differentiating 
spermatogonia (Ikami et al., 2015). Concerning this last point, 
recently, Sharma and Braun revisited the commonly accepted role 
of GDNF. The Authors created a murine model in which the typical 
cyclical pattern of gdnf expression was disrupted so that it resulted 
constitutively expressed in all stages of spermatogenesis. An 
increased number of SSCs was detected, however, it did not match 
with a proportional increase in their Edu labelling index. This 
evidence suggested that GDNF could drive spermatogonial self-
renewal by blocking the differentiation in particular of LIN28
-
 As 
cells into LIN28
+
 As Apr Aal, rather than directly promoting 
proliferation (Sharma & Braun, 2018). On the contrary, Grasso and 
colleagues found that in murine seminiferous tubules Kit mRNA - a 
known marker of differentiating spermatogonia - was significantly 
up-regulated by GDNF at stages II-VIII, suggesting that GDNF 
could have a role in the differentiation of GFRα-1+ spermatogonia 
(Grasso et al., 2012). 
GDNF was also described as a chemoattractant molecule in enteric 
neural cells (Young et al., 2001), in neuronal precursor cells in the 
rostral migratory stream (Paratcha et al., 2006), in epithelial cells 
(Tang et al., 1998), in transformed cells (Okada et al., 1999) and in 
seminoma (Ferranti et al., 2012).  
It is known from literature the non-static nature of SSCs, as well as 
their not stochastic localization on the basal lamina (Chiarini Garcia 
et al., 2001). Moreover, the entire SSCs pool undergoes continuous 
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turnover and a migratory activity of SSCs along the tubule has been 
considered functional to the replacement of SSCs that get lost, from 
neighbouring SSCs (Klein et al., 2010).  Dovere and colleagues for 
the first time demonstrated the direct capacity of the GDNF to 
induce undifferentiated spermatogonia migration in vitro. 
Intriguingly, the more undifferentiated (PLZF-positive) 
spermatogonia were shown to highly express VASP, a member of 
the ENA/VASP protein family that interacts with the actin 
cytoskeleton. The expression of VASP is high in As and Ap and 
decreases to almost undetectable levels in Aal and differentiated 
spermatogonia. In intact seminiferous tubules and germline stem 
cell cultures, GDNF treatment up-regulates VASP in a dose-
dependent fashion. These data suggest that GDNF may impinge on 
the stem/progenitor compartment, affecting the actin cytoskeleton 
and cell migration (Dovere et al., 2013).  
 
 
2.2 Gdnf regulation  
 
GDNF function is crucial for SSCs self-renewal and for whole 
spermatogenesis maintenance, thus it has to be finely regulated. 
GDNF levels are not constant during the seminiferous epithelium 
cycle. In the mouse, both GDNF mRNA and secreted protein swing 
during the 12 stages of seminiferous epithelium, reaching a peak 
around stages II-VI, a decrease at VII-VIII and a minimum at stages 
IX-XI (Grasso et al., 2012). A similar trend was found in rat 
(Johnston et al., 2011) and hamster (Sato et al., 2011). 
Undifferentiated spermatogonia behaviour during the cycle of the 
seminiferous epithelium parallels GDNF fluctuations: from stage XI 
to stage IV they undergo proliferation and become arrested in phase 
G0/G1 at stages III-VI to prepare themselves for differentiationat 
stages VII-VIII. However, the number of As and Apr do not 
significantly vary among the different stages, unlike Aal which 
increase from stage XI to III before going to differentiation at stage 
VII (Tegelenbosch & de Rooij, 1993). 
As the entire spermatogenesis is under the hypothalamic- pituitary 
axis control, the niche factor GDNF is controlled by systemic 
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endocrine factors as well. In particular, GDNF is positively 
regulated by FSH hormone (Tadokoro et al., 2002) on Sertoli cells, 
as they express FSH receptor, FSHR. Because FSHR is not present 
on peritubular cells, GDNF production in peritubular cells does not 
seem to be directly regulated by this hormone (Albrecht et al., 
2006). However, FSH pathway might be dispensable for GDNF 
production in vivo, given that FSHR- null mice are still fertile 
(Dierich et al., 1998; Krishnamurthy et al., 2000). Maximal Sertoli 
cell responsiveness to FSH occurs at stages II-VI (Parvinen et al., 
1980), indeed, gdnf mRNA results induced by FSH in stage II–VI 
and not in other stages (Lamberti & Vicini, 2014). Recently, 
Lamberti and Vicini characterized three cAMP responsive element 
(CRE) implicated in the FSH-induced response of gdnf. These 
regions were localized just upstream the TATA box and 
Transcriptional Start Site 1 (TSS1) and were found to be highly 
conserved among human, mouse and rat (Lamberti & Vicini, 2014) 
(Figure 2). 
 
 
 
Figure 2 Schematic structure of the murine Gdnf gene showing the evolutionarily 
conserved binding sites in the flanking regions of the TSS1 (Lamberti & Vicini, 
2014). 
 
Recently, Hasegawa and colleagues still shed light on cyclical 
activation of MEK/ERK in Sertoli cells, that determines oscillating 
levels of gdnf and promotes the undifferentiated state by inducing 
the expression of GFRα-1/RET. Moreover they identified in a 
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transient pulse of retinoic acid from stage VII an antagonist of gdnf 
expression levels (Hasegawa et al., 2013).  
Testosterone was also demonstrated to stimulate both GDNF 
mRNA and protein in PM cells in vitro (Chen et al., 2014). 
Moreover the loss of Gdnf in PM cells caused a progressive 
depletion of undifferentiated spermatogonia over the long term in 
mice (Chen et al., 2016). On the contrary, is not clear the effect of 
testosterone on gdnf expression in Sertoli cells, even if is well 
established that they respond to testosterone, due to the expression 
of androgen receptor (AR).  An androgen-responsive element (AR) 
highly conserved in mouse, rat and human was found on the 
promoter region of gdnf (Figure 2), suggesting a direct effect of  
testosterone on the expression level of gdnf (Lamberti & Vicini, 
2014). 
 
 
3. Retinoic acid 
 
Retinoic acid (RA) is a small lipophilic molecule, the active 
metabolite of  Vitamin A. It can rightly be considered a morphogen, 
according to the definition as “a secreted molecule that diffuses 
from local sources to form concentration gradients, which specifies 
multiple cell fates” (Schilling et al., 2016). In fact RA signalling is 
a crucial regulator of  the primary body axis of the embryo (di Masi 
et al., 2015).  
RA is formed from circulating retinol (ROL) or from local storage 
of retinyl esters by two sequential oxidative steps: first ROL is 
converted into retinaldehyde by alcohol dehydrogenases (ADH); 
then retinaldehyde dehydrogenases (RALDH) convert retinaldehyde 
in RA. RA controls the gene expression through the binding of a 
heterodimer constituted of the nuclear receptors RAR/RXR (in the 
form of three different isoforms RARα,β,γ and RXRα,β,γ), which 
are located on conserved regions named Retinoic Acid Responsive 
Element (RARE) on the promoter of target genes. RARE elements 
are composed of two hexameric DR (direct repeats) - (A / G) G (T / 
G) TCA - spaced by 5pb (DR5) or 2pb (DR2). For both  DR5 and 
DR2, the 5‟ of the sequence is bound by RXR and the 3‟ by RAR 
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(Cunningham  & Duester,  2015). RARs receptors act as a 
molecular platform to recruit numerous factors that regulate gene 
transcription. In the classical model, the RA-dependent 
transcriptional activation requires that the RAR / RXR heterodimer 
in the absence of retinoic acid binds to the RARE sequence and 
represses the transcription of the target genes also through 
epigenetic modifiers. RAR / RXR in the repressive state recruits co-
repressors such as NCOR-1 (Kumar et al., 2016), the histone 
deacetylases HDACs and the repressive chromatin-remodeling 
complex PRC2 (Polycomb repressive complex 2) (Figure 3 A). 
This leads to an increase in trimethylation of the lysine 27 of 
histone H3 (H3K27me3) which induces chromatin condensation 
and gene silencing. When retinoic acid is present, it binds to RAR 
and induces a conformational change of the RAR/RXR heterodimer 
that promotes the release of repressors and the recruitment of 
factors that activate transcription such as NCOA1 or SRC1, 
NCOA2 and NCOA3. In turn, the co-activators recruits the HATs 
histoneacetylases and the Tritorax complex that remove the 
negative epigenetic modifications (H3K27me3) and add histone 
activating transcription modifications: histone H4 acetylations and 
the histone H3 lysine 4 trimethylation. These modifications induce 
relaxation of the chromatin, allowing access on the promoter of the 
transcription factor target gene and the RNA polymerase. 
The effect of RA on transcription is not always activatory. There are 
examples, in fact, where the RA leads to the repression of the 
transcription, recalling the Polycomb complex and the deposition of 
repressive changes. Some retinoic acid-regulated genes known in 
the literature are fibroblast growth factor (Fgf8), homeobox gene B1 
(Hoxb1), pou5f3 in zebrafish and Wnt8a in mouse (Cunningham & 
Duester, 2015). 
The retinoic acid-dependent pathways also include a non-
transcriptional signalling pathway that activates a kinase cascade 
that will be integrated into the nucleus. Retinoic acid regulates the 
pathway of MAP kinases and ERK kinases by activating p42 / p44 
and p38MAPK (Chung et al., 2010; Dey et al., 2007; Gianni et al., 
2002). In this case the RA is bound by the cytoplasmic portion of 
the RARs that will transmit the signal through the GTPase Rho and 
PI3K. The cascade of phosphorylations converges in the nucleus, 
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with the translocation of the MAPKs, which will activate further 
targets. In the nucleus the protein kinase MSK1 is activated, which 
in turn phosphorylates numerous factors involved in the 
transcription such as histones, RAR receptors and their cofactors 
(Masi et al., 2015)  
 
 
 
Figure 3 A) RA-mediated control mechanism of gene expression.  RA mediated 
transcriptional activation B) RA mediated transcriptional repression 
(Cunningham & Duester, 2015). 
 
 
3.1 Retinoic acid and spermatogenesis 
 
In the testis, nuclear receptors and the enzymes involved in RA 
metabolism are widely expressed, so that the synthesis of RA seems 
to be a synergic process mediated by many cell types. ADH 
(alcohol dehydrogenase) 1 and 3 isoforms in Sertoli cells convert 
ROL into retinaldehyde; ADH4 in late spermatids catalizes the 
same reaction (Deltour et al., 1997; Molotkov et al., 2002). 
Retinaldehyde is converted in retinoic acid by ALDH1A (aldehyde 
dehydrogenase 1A) in Sertoli cells and by ALDH1A2 in germ cells 
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(Arnold et al., 2015). However, the main sources of RA seem to be 
Sertoli cells and pachytene spermatocytes (Endo et al., 2017). 
RA degradation is also important and is mainly controlled by 
peritubular cells which express three cytochrome P450 hydrolase 
CYP26A1, CYP26B1, CYP26C1 (Vernet et al., 2006 B), but also 
within the seminiferous tubules by Sertoli cells and germ cells 
which also express CYP26 enzymes (Hogarth et al., 2015 B). 
The critical role of retinoids in the spermatogenic process was 
strikingly demonstrated by the rodent model fed with Vitamin- A-
deficient diet (VAD) (Wolbach & Howe, 1925). In VAD animals 
only Sertoli cells, undifferentiated spermatogonia and some 
preleptotene were left in the seminiferous epithelium. Then, when 
animals were injected with RA, a massive differentiation of Aal into 
A1 spermatogonia was restored and the blocked spermatocytes 
could initiate meiosis (van Pelt & de Rooij, 1991).  
RA pleiotropic functions could be summarized as follows: 
promotion of Sertoli cell maturation at puberty by suppressing 
proliferation; spermatogonial differentiation (van Pelt & de Rooij, 
1991); induction of meiosis (Koubova et al., 2006); controlling 
blood-testis barrier (BTB) integrity (Morales & Cavicchia 2002);  
spermiation (Vernet et al., 2008); coordinating the adult 
spermatogenic cycle (Sugimoto et al., 2012; Endo et al., 2015).  
In particular, RARγ is the RAR isoform involved in spermatogonia 
differentiation and it is typically expressed in Aal spermatogonia. 
RARγ ablation has demonstrated to not affect meiosis or 
spermiogenesis but to impair Aal transition into A1 (Gely-Pernot et 
al., 2012).  
In germ cells, RA can promote meiotic progression by directly 
stimulating Stra8 transcription, which is a critical gene for meiosis, 
even if its function is still not clarified (Raverdeau et al., 2012). 
Because all the events triggered by RA occur in a synchronized 
fashion around stages VII-VIII, RA was thought to reach a peak in 
that stages. This hypothesis was demonstrated by Hogarth and 
colleagues that for the first time quantified RA local concentration 
in postnatal seminiferous epithelium of the testis (Figure 3 C). The 
Authors used a murine model in which spermatogenesis was 
disrupted through the administration of bisdichloroacetyldiamine 
(WIN18,446), a strong inhibitor of RALDH enzymes, and then 
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spermatogenesis was synchronized with a RA injection (Hogarth et 
al., 2015 A). 
 
 
 
 
Figure 3 C) Schematic representation of RA levels in relation to the stages of the 
seminiferous epithelium (modified by Hogarth et al., 2015 A) 
 
A cyclical metabolism of RA during the cycle of the seminiferous 
epithelium is the basis for oscillating RA levels: in fact, in the first 
part of the cycle, storage of RA seems to be predominant; RA 
synthesis, catalyzed by RALDH enzymes, occurs at stages VII-XII ; 
RA degradation by CYP26 cytochromes takes place after 
spermatogonia differentiation, at stages VIII-XI (Vernet et al., 2006 
B; Sugimoto et al., 2012). In particular, Hogarth and colleagues in 
2015 underlined the stage-specific expression of two enzymes 
responsible for the reversible conversion of retinol into 
retinaldehyde, properly RDH10 (retinol dehydrogenase 10) and 
DHRS4 (dehydrogenase/reductase SDR family member 4) (Hogarth 
et al., 2015 A).  
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In Sertoli cells, the most abundant isoform of retinoids nuclear 
receptors is RARα (Vernet et al., 2006 B). The importance of this 
receptor was attested by KO mice models, which are sterile (Lufkin 
et al., 1993). Moreover, RARα deficient germ cells hardly colonize 
a recipient testis (Doyle et al., 2007). On the contrary, RARβ, 
RARγ and RXRγ null mutants show a normal spermatogenesis 
(Lohnes et al., 1993; Luo et al., 1995; Krezel et al., 1996), RXRβ 
KO mice displayed defects in spermatids maturation and 
spermiation (Kastner et al., 1996), while the effect of RXRα 
absence has not been investigated because RXRα-/-animals die in 
utero (Sukov et al., 1994; Kastner et al., 1994). 
 
While the role of Vitamin A in rodents has been largely 
investigated, the role in human testis is still unknown. For this 
reason, a VAD study in nonhuman primates would be helpful to 
determine the effect of RA depletion in primate testis (Hogarth et 
al., 2011). 
Since the role of RA is crucial in rodents spermatogenesis, 
inhibition of the endogenous biosynthesis of this molecule has also 
been proposed as a contraceptive strategy in men, through the 
inhibition of ALDH1a2 enzymes by the pharmacological compound 
WIN 18, 446 (Heller et al., 1961). However, nowadays, an ideal 
molecule has still to be optimized to reversibly block 
spermatogenesis, without interfering with the metabolism of RA in 
other organs and without generating a disulfiram reaction (Hogarth 
et al., 2011), which is a toxic reaction that causes a reddening of the 
face when consuming alcohol, due to an incomplete metabolism of 
this molecule. 
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AIM 
This study arises in the context of the research activity carried out in 
my laboratory, aimed for years at the study of SSC and its niche, 
both in mouse and in human. 
GDNF is a crucial factor for the self-renewal of spermatogonial 
stem cells (SSCs) which, starting from puberty in the mammal, 
support the continued production of mature germ cells, spermatozoa 
(Meng et al., 2000). In both mouse and human, GDNF is produced 
and secreted by somatic Sertoli cells and peritubular myoid cells. 
Sertoli cells are the main contributors to the formation of SSCs 
niche, a highly specialized micro-environment in which SSC takes 
the so-called "fate decision" i.e. to undertake the differentiation 
process ("commitment") or to maintain the "stemness" (de Rooij, 
2017). In this context, GDNF represents a molecule-paradigm for 
the understanding of the spermatogonial niche. In particular, we 
have shown that the production of GDNF in the seminiferous 
tubules is stage-specific and therefore in a given area of the 
seminiferous tubule its concentration varies cyclically (Grasso et 
al., 2012). Later, we demonstrated that GDNF acts in vitro as a 
chemoattractant for undifferentiated spermatogonia (Dovere et al., 
2013). Since GDNF promotes SSC self-renewal, these data suggest 
that GDNF could facilitate the homing and maintenance of SSCs in 
their niche. The niche is influenced by paracrine factors released by 
different cell types in the testis and endocrine factors such as 
hormones of the hypothalamic-pituitary axis, which therefore 
control the process of spermatogenesis at several levels. We then 
cloned and characterized the murine gene promoter region for active 
GDNF in Sertoli cells. The TSS has been identified, several 
evolutionarily conserved transcription factor binding sites and three 
CRE sites (cAMP-responsive elements) demonstrating the direct 
involvement in FSH-dependent endocrine regulation (Lamberti & 
Vicini, 2014). In recent years, further mechanisms of regulation of 
GDNF expression have been highlighted that make it a finely 
regulated molecule (Garcia et al., 2017). An inhibition of RA-
mediated GDNF levels was described by Saga and colleagues in 
2013. Retinoic acid is an active metabolite of vitamin A with an 
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almost ubiquitous role in cell differentiation and embryonic 
development, as well as in the testis. Retinoic acid is fundamental 
for the differentiation of spermatogonia and, as GDNF, it is 
produced cyclically and in a stage-specific manner in the 
seminiferous tubules. GDNF levels are low in those stages of the 
seminiferous epithelium where retinoic acid levels are high and vice 
versa. This evidence suggests that in vivo GDNF and retinoic acid 
are antagonists in the regulation of the spermatogonial stem 
compartment. Because the molecular mechanism underlying this 
negative regulation is not described, in this thesis we have focused 
our attention on the molecular mechanism by which RA negatively 
affects the expression of GDNF. Primary cultures of  Sertoli cells  
from immature mice (Vicini & Conti, 1997)  and  cultures of 
seminiferous tubules from adult mice were used as experimental 
models (Kotaja et al., 2004). 
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RESULTS   
4. Retinoic acid down-regulates gdnf in immature testis 
 
In order to confirm the evidence reported in the literature by 
Hasegawa (Hasegawa et al., 2013), which describes the down-
regulation of gdnf mediated by retinoic acid in the mouse, we set up 
primary cultures of Sertoli cells, obtained from CD1 mice of 17 
days, according to the protocol described by Vicini & Conti (Vicini 
& Conti, 1997).  
Sertoli cells were treated for 24 hours in the presence of increasing 
concentrations of retinoic acid (RA) from 0,01 M to 10 M. 
Subsequently gdnf mRNA levels were evaluated by Real-Time 
PCR. 
The results showed a negative modulation of the transcript in a 
dose-dependent manner with a significant effect at the concentration 
of 1 M RA (Figure 4 A). 
Moreover, as an internal control of treatment efficacy, we in parallel 
evaluated by Real-Time PCR the induction of stra6 transcript, a 
well-known responsive gene of RA (Bouillet et al., 1997). We 
observed a dose-response increase of stra6 with maximum 
induction with 1 M RA, confirming the efficacy of retinoic acid 
treatment (Figure 4 B). 
 
To evaluate if gdnf RA-dependent regulation was recapitulated in 
testis organ culture, 1 mm
3
 fragments of testicular tissue obtained 
from 17 day-old CD1 mice were cultured for 8 hours in presence of 
1 or 10 M RA. Subsequently gdnf and stra6 mRNA levels were 
evaluated by Real-Time PCR. Gdnf resulted significantly down-
modulated at both concentrations respect to untreated fragments 
(Figure 4 C) as well as stra6 mRNA that was induced with both 
treatments (Figure 4 D). Data suggest that the RA-mediated 
regulation of gdnf in Sertoli cells is still detectable in the immature 
organ culture. 
Because GDNF is a soluble molecule, we then asked if also secreted 
levels were affected by RA. Therefore, GDNF protein levels in the 
conditioned media of Sertoli cells were quantified after 24 hours 
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exposure with 1 M RA or left untreated. The ELISA assay 
performed on three cultures, showed that in the presence of RA 
GDNF levels were lower compared to the control (Figure 4 E). 
 
 
 
 
 
 
A 
B 
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Figure 4 A) Histograms show the regulation of gdnf transcript after 24 hours 
treatment with increasing concentrations of retinoic acid (RA). mRNA levels were 
measured by Real-Time PCR, normalized on β-actin and expressed in fold change 
with respect to the control. Data are shown as mean ± SEM of 3 cultures. ** p 
<0.01 with Student-Newman-Keuls Method B) Histograms showing the 
regulation of stra6 transcript in the same conditions. Data are shown as mean ± 
SEM of 2 cultures. * p <0.05 ANOVA with Dunn's Method. C) Histograms show 
the regulation in murine testicular organ culture of gdnf transcript after 8 hours 
treatment with increasing concentrations of retinoic acid (RA). mRNA levels were 
measured by Real-Time PCR, normalized on β-actin and expressed in fold change 
with respect to the control. Data are shown as mean ± SEM of 3 cultures.               
*  p<0,05 *** p <0,001 with Student-Newman-Keuls Method. D) Histograms 
show  the regulation in murine testicular organ culture of stra6 transcript in the 
same conditions. Data are shown as mean ± SEM of 2 cultures. * p <0,05 **p 
<0,01 with Student-Newman-Keuls Method. E) The histogram shows the effect of 
24 hours RA treatment on secreted GDNF protein in Sertoli cells conditioned 
medium. Data are presented as the mean ± standard error of the mean (SEM) 
from n= 3 cultures. 
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5. RA-dependent gdnf inhibition is quite rapid and does not 
involve neo-synthesis of a repressor 
 
In order to deepen the kinetic of the RA action on gdnf mRNA, 
time-course analysis on RA-mediated regulation was performed on 
Sertoli cells. 
Gdnf mRNA levels after RA treatment were evaluated by Real-
Time PCR at different time points: 20 minutes, 1 hour, 2, 4, 8, 16, 
24 hours. A significant reduction of gdnf mRNA (40%) was 
appreciable not earlier than 2 hours and was maintained for 24 
hours (Figure 5 A). 
To evaluate whether the inhibition of gdnf depended on 
transcriptional stability or required protein synthesis, Sertoli cells 
were treated for 2 hours in the presence of actinomycin D, 
impinging ongoing transcription (actD, 5 μg / ml), or 
cycloheximide, a powerful inhibitor of protein synthesis (CHX, 10 
μg / ml), with or without RA.  
Interestingly, actD treatment alone induced a reduction of about 
80% of gdnf mRNA levels compared to the control, indicating an 
extremely low stability of the mRNA and suggesting that active 
transcription is essential for gdnf mRNA half-life. On the contrary, 
RA and actD co-treatment did not give rise to further appreciable 
lowering of gdnf mRNA compared to actD per se.  
In contrast, treatment with CHX increased mRNA levels, making 
plausible that the ongoing synthesis of a repressor controls basal 
gdnf levels. However, in cells treated with CHX, RA was still able 
to significantly inhibiting mRNA levels. This data suggests that RA 
mechanism of action on gdnf transcript does not require protein 
synthesis (Figure 5 B). 
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Figure 5 A) The histogram shows the effect of different time treatment with 1 uM 
RA on gdnf mRNA in primary cultures of murine Sertoli cells. The mRNA levels 
were quantified by Real-Time PCR, normalized on β-actin and expressed as mean 
± SEM from 2 cultures and expressed in fold change compared to the untreated 
control. *** p <0,001 with t-test  5 B) Histogram shows the regulation in Sertoli 
cells of gdnf transcript after 2 hours treatment with actinomycinD (actD) or 
cycloheximide (CHX) in the presence or absence of RA. The mRNA levels were 
quantified by Real-Time PCR, normalized on β-actin and expressed as mean ± 
SEM from 2 cultures and expressed in fold change compared to the untreated 
control.  * p <0.05 with ANOVA (Dunn's Method) on Ranks. 
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6.   RARα inhibition impinges gdnf down-regulation  
 
To determine whether the down-regulation of gdnf involved the 
nuclear retinoic acid receptors RARs, Sertoli cells were treated with 
BMS-204493, inverse agonist inhibitor of all three RARs isoforms 
(RARα, RARβ and RARγ) (Raverdeau et al., 2012). Cells were pre-
treated for 2 hours in the presence of 10 M BMS-204493, and 
thereafter, 1 M RA was added to the culture medium for 24 hours. 
At the end, gdnf mRNA levels were measured. Real-Time PCR 
results show the statistically significant reduction of gdnf levels 
after retinoic acid treatment compared to controls. Treatment with 
BMS-204493 alone did not modulate gdnf baseline levels but when 
retinoic acid was added, a significant down-regulation was no 
longer appreciable (Figure 6 A). 
As an internal control of the effectiveness of the pharmacological 
inhibitor, the levels of stra6 mRNA were measured. The treatment 
with BMS-204493 negatively affects basal levels of stra6 and 
significantly blocks the induction of stra6 by RA (Figure 6 B) 
Since RARα is the most expressed isoform in Sertoli cells (Vernet 
et al., 2006 B), we investigated the involvement of this specific 
isoform, treating Sertoli cells in the presence of RO41-5253, a 
selective pharmacological antagonist of RARα (Ertesvag et al., 
2007). Cells were pre-treated for 2 hours with 3,5 M RO41-5253, 
and then 1 M RA was added to the culture medium for the next 24 
hours, then the levels of gdnf and stra6 were analyzed by Real-Time 
PCR. In the presence of RO41-5253, the inhibitory effect of RA on 
gdnf mRNA was reversed, while the basal levels were not affected 
(Figure 6 C). Regarding stra6 mRNA, both basal and induced levels 
were strongly reduced (Figure 6 D). These data suggest that the 
effect of RA on gdnf expression depends on the RARα nuclear 
receptor activity. 
We then examined the effect of RARα ablation performed by RNA 
interference (RNAi) using small interfering RNA (siRNA) against 
RAR mRNA. Sertoli cells were transfected for 5 hours with 250 
picomoles / well anti RAR siRNA or with a scrambled siRNA, 
conveyed by 5 l / well Lipofectamine2000. At the end, cells were 
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treated for 24 hours in the presence or absence of 1 M RA and 
levels of gdnf were measured by Real-Time PCR.  
The administration of anti RAR siRNA lowered RAR mRNA 
levels by around 70% respect to the scramble sequence (Figure 6 
E). As expected, RA was able to down-regulate gdnf mRNA in 
Sertoli cells transfected with the scramble RNA. Conversely, in 
cells where RAR was interfered, RA did not lower gdnf levels 
(Figure 6 F). This approach confirmed the RAR involvement in 
gdnf regulation and strengthened previous conclusions obtained 
using the pharmacological inhibitors.  
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Figure 6 Effect of treatment with BMS-204493 on the levels of gdnf mRNA A) 
and stra6 B) in the presence or absence of RA.  A) Data are represented as mean 
± SEM from 4 cultures * P <0,05 with Dunn's Method.  B) Data are represented 
as mean ± SEM from 3 cultures * p <0,05 with Dunn's Method. 
Effect of the treatment of Sertoli cells with 3,5 M RO41-5253 for 24 hours on 
the levels of gdnf C) and stra6 D) in the presence or absence of RA, measured by 
Real- Time PCR. Data are represented as mean ± SEM from 3 cultures. C) *p 
<0,05 *** p <0,001 with All Pairwise Multiple Comparison Procedures Tukey 
Test) D) * p <0,05 with All Pairwise Multiple Comparison Procedures ( Tukey 
Test) on Ranks.  
E) Effect of the anti-RARα siRNA on rarα transcript F) Effect of the treatment 
with scramble or anti-RARα siRNA on gdnf levels in the presence or absence of 
RA,  measured by Real- Time PCR. Data are represented as mean ± SEM from 2 
cultures * P <0,05 with Dunn's Method.  
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7. Gdnf regulation depends on its promoter 
 
We asked, therefore, whether the action of RA on gdnf mRNA 
levels involved the 5'-flanking regulatory region of the gene. To 
clarify the role of the promoter in the regulation of gdnf, we 
investigated the activity of the promoter by luciferase assays. 
Sertoli cells were transiently transfected with a plasmid vector 
containing the 5'-flanking region of the gene Gdnf (-1857 / + 109) 
upstream of the luciferase gene (Lamberti & Vicini, 2014) and 
treated in the presence or absence of 1 M RA for 24 hours. At the 
end of the treatment, luciferase activity was measured in cell 
extracts. The activity is expressed as RLU (Relative Light Units) 
corrected for g of proteins. Retinoic acid reduces of about 40% of 
the luciferase activity compared to the control. These results 
indicate that the 5'-flanking region of the gene (-1857 / + 109) 
contains gene sequences implicated in the negative regulation of the 
levels of mRNA exerted by RA (Figure 7). 
Since the presence of a Retinoic Acid Responsive Element on the 
5'-flanking of the murine Gdnf gene is not known from the 
literature, we performed an in-silico analysis using the Softberry 
software, detecting the presence of a RARE DR5 5'-
TGACCTCTCCCTGATCA-3‟ sequence on the murine Gdnf 
promoter (mus musculus), just upstream of the 3 CRE regions 
(Cyclic AMP Responsive Element) evolutionarily conserved in 
mouse, rat and man, previously identified by our group (Lamberti & 
Vicini, 2014). In order to demonstrate the involvement of this 
region, we performed a site-specific mutation of the DR5 in the 
genomic fragment (-1857 / + 109). With this mutated construct we 
transfected cells and measured luciferase activity, in the presence or 
absence of RA. The results show that the mutation of the putative 
DR5 binding site reverts the inhibition of RA treatment on 
luciferase activity (Figure 7 B). This suggests that the DR5 
sequence identified in-silico is critical in RA mediated regulation 
confirming the involvement of RAR nuclear receptors (Figure 7 C) .  
 
  
 
PhD in Morphogenesis and Tissue Engineering 
 
37 
 
 
 
 
 
 
 
 
Rossana Saracino 
 
38 
 
 
 
 
 
 
Figure 7 A) Schematic representation of the GDNF promoter with the RARE 
putative site (modified by Lamberti & Vicini,, 2014) B) Effect of treatment with 
retinoic acid on the luciferase activity carried by wild-type and mut-DR5 RARE 
constructs transiently transfected in Sertoli murine cells. Luciferase activity was 
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expressed as Relative Light Units (RLU) and normalized for micrograms of cell 
lysates  proteins. In the graph, the histograms show a representative experiment 
expressed as mean± SD. C) Schematic representation of the GDNF promoter 
with the RARE putative site (modified by Lamberti et al., 2014) 
 
 
8. RAR binds on Gdnf promoter 
 
To directly demonstrate RAR occupancy on the putative DR5 
RARE, we performed ChIP-qPCR experiments. 
 
Sertoli cells were cultured with or without RA for 2 hours, and the 
enrichment mediated by the RAR antibody was measured to 
evaluate the recruitment at the  DR5 RARE (Figure 8). The results 
demonstrate that both in basal and RA treatment conditions RAR 
occupy the DR5 RARE. 
 
 
 
Figure 8) Real-time PCR amplification of the promoter region of Gdnf in the 
DNA derived from Sertoli cells untreated or treated with 1 M RA for 2 hours, 
immune-precipitated using the RAR antibodies or with beads without antibody 
as negative control (noAb). Data are reported as increase relative to the 
percentage of input. 
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9. RA-dependent gdnf inhibition is prevented by HDACi  
 
The RA classical genomic effect on target genes transcription is 
more often stimulatory. In the few documented cases of direct 
genomic repressive action mediated by RA, recruitment of HDACs 
enzymes seems to be involved (Cunningham & Duester, 2015).  
We then tested the hypothesis of the involvement of  this class of 
enzymes in RA mechanism of action on the Gdnf gene. To this 
purpose, we tested the effect of two different inhibitors of class I 
and II histone deacetylases (HDACs), SAHA and Valproic acid 
(VPA) (Dokmanovic et al., 2007). 
Sertoli cells were treated for 2 hour with 1,25 M SAHA or 1 mM 
VPA in the presence or absence of 1 M RA. The expression of the 
transcript of gdnf was analyzed by Real-Time PCR. 
The treatment with SAHA significantly reversed the RA-mediated 
inhibitory effect on gdnf  (Figure 9 A). The treatment with VPA 
also had the effect to inhibit gdnf basal levels and the inhibitory 
effect of RA was no longer appreciable (Figure 9 B). These data 
suggested that histone deacetylases could be involved in this 
regulation. 
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Figure 9) Effect of HDACi on the transcription levels of gdnf, in the presence or 
absence of RA, measured by Real-Time PCR. A) Effect of SAHA  and B) Valproic 
Acid administration . 
Values are expressed as mean ± SEM of 3 independent experiments * p <0.05 
with Dunn's Method. 
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10. RA-dependent gdnf inhibition is based on promoter de-    
acetylation 
 
The previously obtained results suggest the presence of an 
epigenetic mechanism at the base of the RA negative regulation on 
the Gdnf promoter.  
To directly verify this hypothesis, we performed ChIP-qPCR 
experiments to evaluate the acetylation levels of histone H4 in a 105 
bp region straddling the transcriptional start site 1 (TSS1) of the 
Gdnf promoter, in the presence or absence of RA. 
Sertoli cells were cultured with or without RA for 2 hours, and at 
the end the enrichment mediated by the anti-H4 acetylated antibody 
(H4Ac) was measured to evaluate the acetylation status of a 
promoter fragment around the 105 bp long (Figure 10). The results 
demonstrate that RA treatment induces a significant reduction of 
histone H4 acetylation levels in the region around the TSS1, 
suggesting that the RA-mediated negative regulation is based on 
epigenetic mechanisms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 Real-time PCR amplification of the promoter region of Gdnf in the 
DNA derived from Sertoli cells untreated or treated with 1 M RA for 2 hours, 
immune-precipitated using the anti-H4-Ac antibodies or with beads without 
antibody as negative control (noAb). Data are reported as increase relative to the 
percentage of input. 
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11. gdnf RA-mediated regulation is conserved in adult mouse 
and is stage-dependent  
 
To assess whether RA-mediated gdnf regulation was conserved in 
the sexually mature mouse, and since it is impossible to obtain pure 
Sertoli cultures from the adult testis, we cultured for 8 hours 1 mm
3
 
fragments of testicular tissue obtained from 3 month old mice in 
presence of 1 or 10 M RA. Subsequently gdnf and stra6 mRNA 
levels were evaluated by Real-Time PCR. However, in those culture 
conditions, neither of the two RA concentrations lowered gdnf 
mRNA levels (Figure 11 A) or significantly affected stra6 mRNA 
(Figure 11 B). 
Because in adult testis the concomitant presence of multiple germ 
cell associations and cellular subtypes could hide a subtle gene 
regulation, we  decided to put in culture isolated and staged 
seminiferous tubules from 3 month old CD1 mice. Seminiferous 
tubules were divided into three groups of stages (stages II-VI, VII-
VIII and IX-XI) and for each group 3 cm total length were isolated. 
Tubules were kept in culture for 4 hours, in the presence or absence 
of 1 M RA, and mRNA levels assessed by Real-Time PCR. In line 
with data already published by our laboratory, the gdnf baseline 
levels were found oscillating, high in stages II-VI, and lowered in 
stages VII-VIII and IX-XI (Grasso et al., 2012). The negative 
regulation mediated by RA was significant detected only in stages 
II-VI (Figure 11 C). We measured stra6 levels which were also 
showily stage-dependent, lower at stages II-VI and IX-XI and very 
high at stages VII-VIII. Again, RA stimulation induced stra6 
expression only in stages II-VI (Figure 11 D). These data suggest 
that the RA-mediated regulation of gdnf and stra6 transcripts are 
detectable in isolated seminiferous tubules from adult testis. 
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Figure 11) Histograms show the regulation in murine testicular organ culture of 
gdnf transcript A), and stra6 transcript B) after 8 hours treatment with 1 or 10 
RA. mRNA levels were measured by Real-Time PCR, normalized on β-actin and 
expressed in fold change with respect to the control. 
Expression of gdnf C) stra6 D) in staged seminiferous tubules cultured for 4 
hours in the presence or absence of RA. The mRNA levels were evaluated by 
Real-Time PCR , normalized on β-actin levels and expressed as fold changes on 
the II-VI stage controls. Data are represented as means ± SEM of three 
experiments. The statistical analysis used the T test to compare the RA treatment 
with respect to its control, for each group of stages. * p <0.05 ** p <0.01 
 
12. RA could act as an indirect regulator of gdnf   
 
We then asked if RA could exert an indirect effect on gdnf cyclical 
regulation in the seminiferous epithelium. Because the expression 
profile of gdnf during the cycle of the seminiferous epithelium 
parallels the profile of the FSH response in rat, which is high in 
stages XIII–V and decreases subsequently (Parvinen et al., 1980; 
Parvinen, 1982), we asked if the variations in FSH response, which 
contributes to gdnf levels oscillations, were linked to RA. With this 
aim, we examined FSH receptor (fshR) mRNA expression in 
primary Sertoli cells (Figure 12 A) treated for 24 hours with RA,  
and we found lowered FshR mRNA levels. Then, we evaluated the 
same effect on staged seminiferous tubules, with or without 4 hours 
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1 M RA stimulation. We found that fshR basal levels higher at 
stages II-VI and lower at VII-VIII and IX-XI stages, confirming 
similar evidences in literature (Heckert & Griswold, 1993) and that 
the addiction of 1 M RA significantly reduced fshR mRNA at 
stages II-VI but not in other stages.  
 
 
 
 
 
 
Figure 12 A) Effect of 24 hours treatment with 1 uM RA on fshR mRNA in 
primary Sertoli cells. Data are expressed as mean ± SEM of two cultures and The 
mRNA levels were evaluated by Real-Time PCR, normalized on β-actin levels and 
expressed as fold change on the untreated. The statistical analysis used the T test 
to compare the RA treatment with respect to its control **p<0.01 B) Expression 
of fshR in staged seminiferous tubules cultured for 4 hours in the presence or 
absence of RA. The mRNA levels were evaluated by Real-Time PCR, normalized 
on β-actin levels and expressed as fold change on the II-VI stage controls. Data 
are represented as means ± SEM of three experiments. The statistical analysis 
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used the T test to compare the RA treatment with respect to its control, for each 
group of stages. *** p <0.001  
13. Gdnf RA-dependent regulation in human testis 
 
We next asked whether RA could be a regulator of gdnf also in 
human testis.  
With this aim, we prepared human testicular organ cultures 
according to the “hanging drop” protocol (Jørgensen et al., 2014). 
Fragments from testicular biopsies obtained from heart-beating 
organ donors (19y-85y) were cultured for 8 hours in αMEM 
medium containing 1 or 10 M RA.  
Sertoli cell responsivity to RA was assessed measuring stra6 
induction by Real-Time PCR. Stra6 was found up-regulated in a 
significant manner at 1 M RA (Figure 13 A and B).  
Overall, gdnf expression was not affected by RA treatment at both 1 
and 10 M (Figure 13 C). However, analysis of single donors 
revealed that a negative trend was appreciable in 6 out of 10 donors 
while 4 donors exhibited an opposite behavior with a strong up-
regulation of gdnf (Figure 13 D). Taken together these results, 
indicate that RA-mediated gdnf regulation in human testis is 
heterogeneous. 
 
 
 
 
 
 
Rossana Saracino 
 
48 
 
 
 
 
 
 
 
 
PhD in Morphogenesis and Tissue Engineering 
 
49 
 
 
 
 
 
Figure 13 The graphs show boxplot (A, C) or single donors behavior (B, D) 
about the expression of stra6 (A, B) and gdnf mRNA (C, D) in human testicular 
hanging drop cultures. The mRNA levels were evaluated by Real-Time PCR, 
normalized on rps29 mRNA levels and expressed as fold change on the controls. 
Data are represented as medians ± SEM. *p<0.05 with Dunn’s Method. 
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DISCUSSION 
GDNF and RA are two crucial molecules for spermatogonial 
compartment  The first, secreted by somatic Sertoli cells, stimulates 
SSCs stemness, the second, released within the testicular 
microenvironment, stimulates spermatogonial progression. Both 
molecules are known to be crucial for spermatogenesis: ablation of 
GDNF and depletion of intra testicular RA led to spermatogenesis 
disruption (Meng et al, 2000; Wolbach & Howe, 1925). 
In murine testis, a negative regulation of GDNF by RA was recently 
described by Hasegawa and colleagues but the mechanisms behind 
were not clear (Hasegawa et al., 2012). With the aim to understand 
the molecular mechanism underlying this regulation, we used 
murine primary Sertoli cell cultures as a model and firstly we 
confirmed the down-regulation of gdnf following 1 M RA, which 
is the concentration commonly used in literature for testicular 
treatments (Childs et al., 2011; Jørgensen et al., 2015). We 
demonstrate that RA-mediated gdnf regulation takes 2 hours and 
affects both mRNA and secreted protein levels. Protein synthesis 
was found dispensable for RA-mediated gdnf regulation but 
blocking ongoing transcription with ActD lowered gdnf mRNA by 
80%. This suggests that gdnf transcripts have a short half-life, a 
feature that may contribute to gdnf transcripts oscillation during the 
8,6 days of the cycle of the seminiferous  epithelium (Grasso et al., 
2012; Sharma & Braun, 2018).  
Immature and adult Sertoli cells express RAR and RXRβ, 
therefore we hypothesized an involvement of RAR in the 
regulation of gdnf  (Vernet et al., 2006). Here we show that ablation 
of RAR, performed both with a selective pharmacological 
antagonist and with a specific designed siRNA, was able to 
completely revert RA-mediated negative regulation. This data are in 
line with the observation that in vivo overexpression of a dominant 
negative form of RAR reverts RA-negative gdnf regulation 
(Hasegawa et al., 2013). 
The murine Gdnf gene has three alternative promoters, among 
which, promoter 1  upstream of exon 1 is the only active in Sertoli 
cells. In promoter 1, the TSS1 is located approximately 30 bp 
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downstream from the canonical TATA-box sequence and 
approximately 900 bp upstream from the putative initiation of 
translation (Lamberti & Vicini, 2014). In Sertoli cells transiently 
transfected with the 1,7 kb 5‟ flanking-region of  TSS1, a 
significant reduction of  luciferase activity over basal conditions 
was measured in RA-treated cells. This was consistent with the 
presence of a retinoic responsive element (RARE) upstream of 
TSS1 and  prompt us to search for RARE by in silico analysis. A 
novel DR5-RARE (5‟-TGACCTCTCCCTGATCA-3‟) was indeed 
identified located 307 bp upstream of TSS1 (Lamberti & Vicini, 
2014). Two line of evidence strongly suggest that DR5-RARE is 
involved in RA-modulation of gdnf expression level: i) deletion of 
DR5-RARE in the 1,7 kb 5‟ flanking-region of  TSS1 completely 
reverted the RA-mediate inhibition of luciferase activity; ii) DR5-
RARE is occupied by RAR both in control and RA-treated cells as 
measured by Chip-qPCR analysis.   
While the RAREs-mediated transcriptional activation is well 
established (Germain et al., 2002), the mechanism by which RA 
represses transcription on the promoter of target genes is less 
known. The little information available on this type of regulation is 
based on few evidences, among whom studies on Fgf8, in which 
action of RA causes repressive changes around RARE on the 
promoter (Kumar & Duester, 2014). This prompted us to evaluate 
epigenetic mechanisms. Because a repressive action of RA with 
recruitment of HDAC complexes has been reported in literature, we 
investigated the effect on RA-mediated gdnf regulation of two 
pharmacological compounds, SAHA (Vorinostat) and Valproic 
Acid, which respectively inhibit class I and II, and class I and IIa 
HDAC enzymes (Dokmanovic et al., 2007). In the presence of both 
drugs, RA effect on gdnf was no more evident. Reduced acetylation 
on Gdnf promoter was directly confirmed by ChIP-qPCR 
experiments showing that RA is able to modify the epigenetic 
profile of the TSS1 region, inducing  de-acetylation of histone H4 
with respect to the basal condition. This is in line with the model for 
RA-mediated gene repression proposed by Cunningham and 
Duester which predicts that, in the presence of RA, RARs recruits 
co-factors such as NCOR1 and NCOR2, PRC2 and HDAC 
complexes on the promoter of target genes (Cunningham & 
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Duester, 2015; Kumar et al., 2016). Subsequent experiments of 
Chip-qPCR will be used to test this model for the recruitment of 
corepressors on the Gdnf promoter in the presence of RA.  
To evaluate whether RA-mediated gdnf modulation is also 
conserved in the adult testis, and because is not possible to obtain 
pure Sertoli cell culture form adult testis, we used in vitro testis 
organ cultures. In organ cultures, direct and indirect interactions 
between somatic testicular cells and germ cells are maintained, 
mimicking the in vivo situation. However, in these experimental 
conditions we did not find a significant gdnf modulation upon RA 
treatment probably due to a catabolic barrier preventing RA from 
entering the seminiferous tubules (Vernet et al., 2006b). Therefore 
we employed a different in vitro model i.e., staged seminiferous 
tubules from adult mouse (Grasso et al., 2012). In line with 
previous data, we here show that basal gdnf levels are cyclical, 
higher at stages II-VI and lower at VII-VIII and IX-XI (Grasso et 
al., 2012). RA treatment significantly reduced gdnf transcription at 
stages II-VI, but not at VII-VIII and IX-XI. Interestingly, also RA-
mediated stra6 induction occurred only at stages II-VI. These 
results suggest that RA-mediated gdnf regulation is conserved in 
adult testis but is detected only in stages where the endogenous 
levels of RA are low (i.e II-VI) and not in stages VII-VIII where the 
endogenous levels of RA are maximal. However, RA did not 
mediate further gene regulation also at stages IX-XI. The absence of 
RA response may suggest that the RA refractory effect could 
continue until stage XI. This is in line with  Hasegawa and Saga 
(Hasegawa & Saga, 2012), also supported by Page (Endo et al., 
2015), that assumes that RA levels grow at stages VII and keep high 
until stage XII. 
Our data point to a direct regulation of RA of the Gdnf promoter 
through the DR5-RARE and epigenetic modification. We also 
asked if RA could indirectly control cyclical gdnf expression by 
antagonizing the gdnf “supporting” pathways in Sertoli cells. Gdnf 
expression in Sertoli cells is activated by MEK/ERK signaling, but 
MEK/ERK and RA pathways were shown to be independent from 
each other (Hasegawa & Saga, 2013). As FSH is an important gdnf 
stimulating factors both in vitro and in vivo, we asked if RA could 
antagonize FSH (Takodoro et al., 2002; Grasso et al, 2012; Lambert 
Rossana Saracino 
 
54 
 
&Vicini, 2014). We showed that in vitro, RA down-regulate FSH 
receptor mRNA both in immature and in adult testis. In particular, 
we found a cyclical expression of  fshR mRNA, with a minimum at 
stages VII-VIII, confirming similar evidences in rat (Heckert & 
Griswold, 1993). These data indicate that RA may also indirectly 
affect gdnf levels by reducing FSH receptor levels. 
Respect to the rodents model, the availability of human testicular 
biopsies for research purposes is extremely limited. For this reason, 
the understanding of spermatogenesis is fundamentally based on 
rodents and other primates studies. Even though the pivotal role for 
GDNF in rodent spermatogenesis is largely recognized, nothing is 
known about the role of the GDNF/GFRA1/Ret pathway in the 
human spermatogonial compartment. In human testis, the source of 
GDNF comprises Sertoli cells (Davidoff et al., 2001) and myoid 
peritubular cells (Spinnler et al., 2010, Chen et al., 2014; Chen et 
al., 2016). Moreover, a large subset of human undifferentiated 
spermatogonia, including the most primitive spermatogonia, express 
the GDNF co-receptor GFRA1, implying a possible physiological 
role of GDNF also in human spermatogenesis (Grisanti et al, 2009; 
Di Persio et al., 2017). Recent data from NOA and SCO patients 
suggest that GDNF in the human testis may a function similar to 
that of rodents (Ma et al., 2013; Singh et al., 2017). Regarding the 
role of Vitamin A in human testis, very little is known (Hogarth et 
al., 2011). However, RA seems to play a critical role in human 
spermatogenesis, since impinging testicular RA biosynthesis by 
inhibiting ALDH1a2 enzyme, reversibly blocks spermatogenesis in 
men (Heller et al., 1961). Here we investigated the gdnf regulation 
in human testis by in hanging drop cultures. RA treatment induces a 
significant up-regulation of stra6 mRNA indicating that testicular 
cells are responsive to RA. On the contrary, there was no statistical 
significance of the effect of  RA on gdnf expression. Interestingly, 
out of 10 samples, a negative trend was appreciable in six donors, 
while gdnf was up-regulated in four donors, indicating an 
heterogeneous response. The physiological function of GDNF and 
RA in human spermatogenesis certainly deserves further 
investigation. 
To conclude, our results can ameliorate the comprehension of the 
SSCs niche functioning and its complex molecular network.  Our 
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study is also the basis for further studies concerning the niche of 
SSCs in its physiological conditions but also in relation to the ever 
increasing number of cases of male infertility in which its balance 
could be compromised. Moreover can shed light on the RA-
mediated gene repression of target genes. 
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MATERIALS AND METHODS 
Primary culture of murine Sertoli cells 
 
Primary cultures of Sertoli cells were obtained from 17-day CD1 
mice, as previously reported (Vicini & Conti, 1997). Isolated testes 
were washed twice with Hank's solution (Sigma) and the tunica 
albuginea was removed. Subsequently testes were chopped, 
transferred to a Hank's solution containing 0.002% DNAse I 
(Roche), 0.25% Trypsine (Difco) and agitated at 32 ° C for 13 
minutes. The digestion was blocked by adding 10% fetal bovine 
serum. The seminiferous tubules were deposited for 4 minutes at 
unit gravity and washed twice with Hank's solution. The second 
digestion was performed with a solution of Hank's, 0.002% DNAse 
I (Roche) and 0.2% of Collagenase A (Roche) at 32 ° C for 20 
minutes, with agitation. At the end, the fragmented tubules were 
deposited at unit gravity, washed with Hank's solution, collected in 
a polystyrene tube and subjected to centrifugation at 18 g for 2 
minutes. The pellet was then resuspended in MEM 1X (Minimum 
Essential Medium) (Gibco), containing 20 mM glutamine, Hepes 
0.01 M, non-essential 0.1 mM amino acids and antibiotics.  
The suspension with the fragments of seminiferous tubules is plated 
in 10 mm plates (9 ml of suspension) or in multiwell plates (6 
wells) of 35 mm of diameter (1.5 ml of well suspension) and 
maintained at 34° C in a controlled atmosphere of 5% CO2.  
With this procedure, a monolayer is formed consisting exclusively 
of Sertoli cells and germ cells. To remove the residual germ cells, 
after 48 hours a hypotonic solution (TrisHCL 20mM pH 7.4) was 
administered to selectively eliminate germ cells (Galdieri & Zani, 
1981). Sertoli cells can then be used after 24 hours from hypotonic 
treatment. 
Sertoli cells treatments 
 
24 hours after hypotonic treatment, Sertoli cells are treated at 34° C  
5% CO2 with RA (Sigma-Aldrich, Milan, Italy); ActD (5 μg / ml) 
(Sigma-Aldrich, Milan, Italy); CHX (10 μg / ml) (Sigma-Aldrich, 
Milan, Italy; BMS-204493 (Sigma-Aldrich, Milan, Italy); RO41-
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5253 (Santa Cruz Biotechnology); Valproic acid (Sigma-Aldrich, 
Milan, Italy);  SAHA  (Sigma-Aldrich, Milan, Italy). 
 
Testicular organ culture 
 
17-day CD1 mice or adult CD1 mice (3 months) were sacrificed, 
testes were taken, deprived of tunica albuginea and transferred to a 
plate with PBS. Testicular fragments of 1 mm
3 
were cut and placed 
on steel grids coated with 2% agar in organ culture dishes and 
maintained at 34 °C in a controlled atmosphere of 5% CO2. PBS 
was added to the bottom of the dish to maintain fragments 
hydration. 
 
Seminiferous tubules isolation 
 
Adult CD1 mice (3 months) were sacrificed, testes were taken, 
deprived of tunica albuginea and transferred to a plate with PBS. At 
the stereomicroscope, with 25-50X enlargement, tubules were 
dissected and stages of the seminiferous epithelium identified 
through the different pattern of light absorption by transillumination 
(Kotaja et al., 2004). The greatest differences in light absorption are 
due to the presence and disposition of spermatids. Three groups 
were isolated: low-density spermatids characterize a pale area 
which include the IX-XI stages; a greater number of spermatids 
located internally to Sertoli cells represents the dark spot area in 
stages II-VI; in the last stages of maturation, the spermatids form a 
continuous layer above the seminiferous epithelium which gives 
rise to a dark absorption pattern (dark area) in the VII-VIII stages 
(Figure 14). 
For each group, 3 cm total length were measured, collected and 
cultured for 4 hours with MEM 1X (Gibco) medium with or without 
1 μM RA, for subsequent mRNA extraction. 
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Figure 14 Absorbance pattern of stages II-VI, VII-VIII e IX-XI (Pelletier, 2011) 
 
RNA extraction and Real-Time PCR 
 
Total RNA extraction was performed using the TRIzol reagent 
(Invitrogen) following the manufacturer's instructions.  
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The obtained RNA was quantified by spectrophotometer (Nanodrop 
Microvolume Quantitation of Nucleic Acids).  
The cDNA synthesis, from 1 µg of RNA for each sample, was 
performed using the High-Capacity RNA-to-cDNA™ Kit (Thermo 
Fisher Scientific, Waltham, MA, 02451 USA)  in a thermal cycler 
for 60 minutes at 37°C followed by 5 minutes at 95°C for the 
enzyme inactivation. A control sample, without the reverse 
transcriptase, was used to evaluate the presence of genomic DNA. 
The cDNA was subjected to Real-Time PCR analysis performed in 
duplicate for each sample with FluoCycleTMII SYBR Green Mix 
(Euroclone) in 7500 Real-Time PCR System (Applied Biosystems, 
Life Technlogies, Monza, Italy).  
Data were analyzed with the comparative  2
−ΔΔCT
  method using β-
actin for mouse and rps29 for human as reference genes and control 
conditions as calibrator.  
Primers sequences, designed using Primer BLAST software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast), are listed in Table 
1.  
 
gene primers 
gdnf (mus musculus) Fw TTGCATTCCTGCTACAGTGC 
gdnf (mus musculus) Rev GGTGGCTACCTTCCTCCTTC 
stra6 (mus musculus) Fw ACACTCCACAGCCAGGATTC 
stra6 (mus musculus) Rev ACATCTGTGTTGATCCCCGC 
rar (mus musculus) Fw GATCACAGACCTTCGGAGCACGA 
rar (mus musculus) Rev CGACTGTCCGCTTAGAGTGT  
fshR (mus musculus) Fw ACAGGGTCTTCCTCTGCCAA 
fshR (mus musculus) Rev TTTCTCCAGGTCCCCAAATCC 
β-actin (mus musculus) Fw TGACAGGATGCAGAAGGAGA 
β-actin (mus musculus) Rev GTACTTGCGCTCAGGAGGAG 
gdnf (human) Fw GCAGACCCATCGCCTTTGAT 
gdnf (human) Rev CCACACCTTTTAGCGGAATGC 
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stra6 (human) Fw GCTTCAGCCGTAGGACAGGA 
stra6 (human) Rev AGCTTCTTCCTGCAAAGGAGGT 
rps29 (human) Fw CGCTCTTGTCGTGTCTGTTCA 
rps29 (human) Rev CCTTCGCGTACTGACGGAAA 
  
Table 1 : list of the primers used for Real-Time PCR 
 
Short interference RNA (siRNA)  
 
To interfere the RAR protein, a specific siRNA was designed with 
the INVIVOGEN software (5'-
GGAAGCACUGAAAGUCUACGU-3'  strand + 5'-
ACGUAGACUUUCAGUGCUUCC-3'  strand -) 
Sertoli cells after the hypotonic treatment were grown in the 
absence of antibiotics and  transfected for 5 hours with 5 l / well 
Lipofectamine 2000 (Invitrogen) and 250 picomoles of the anti 
RAR siRNA or MISSION siRNA Universal Negative control 
(Sigma) in Opti-MEM medium (Invitrogen). At the end of the 
treatment, medium was removed and MEM 1X (Gibco) was added 
for the following 24 hours in the presence or absence of 1 M RA. 
 
Plasmid mutation 
 
To obtain internal deletion of the GDNF genomic promoter, the 
QuikChange II XL Site-Directed Mutagenesis Kit (Agilent 
Technologies, Milano, Italy) was employed. Briefly, we performed 
a PCR associated technique to create deletion mutants of the 
construct using primers carrying the appropriate deletions of the 
region of interest, following the manufacturer‟s directions (Agilent 
Technologies, Milano, Italy). Primer couples (forward and reverse) 
were designed to keep the mutation in the middle of the primer. 
After PCR extension, the reaction was used to transform XL-10 
gold bacteria. Several bacterial colonies were selected and 
sequenced to evaluate introduction of the desired mutation.  
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Primers used for mutagenesis on Gdnf promoter are listed in table 2.  
 
Primers  
forward GGCAGGTTTATGCCCTACCTTCCCAGTGATCTTACGCCTCTGG 
reverse CCAGAGGCGTAAGATCACTGGGAAGGTAGGGCATAAACCTGCC 
  
Table 2: primers used for the plasmid mutation. 
 
Luciferase assay and protein normalization 
 
Sertoli cells after the hypotonic treatment were grown in MEM 1X 
medium (Gibco) in the absence of antibiotics for 24 hours. The next 
day cells were transfected using Lipofectamine 2000 (Invitrogen) 
and 1,5 g / well of the control plasmids without a promoter (Pgl2-
luciferase), wild type (-1857 / + 109-luciferase) or with the RARE 
DR5 site mutated (mut DR5: -1857 / + 109-luciferase) and cultured 
in Opti-MEM medium (Invitrogen). After 5 hours, the medium was 
removed and the cells grown with MEM 1X (Gibco) with or 
without 1μM RA for following 24 hours. At the end cells are 
washed with PBS and lysed in 1x Passive Lysis Buffer (Promega) 
and luciferase activity was measured with Luciferase Assay System 
(Promega) at the GloMax Discover luminometer (Promega). The 
activity was expressed in relative luminescence units (RLU) and 
normalized for g of proteins, quantified with BCA assay (Thermo 
Scientific). 
 
ChiP assay 
 
Sertoli cell cultures were treated for 2 hours in the presence or 
absence of 1μM RA, then cross-linked with 1% formaldehyde 
(Sigma). After two lysis steps, the cell chromatin was sonicated to 
obtain fragments of about 800-500 bp. The size of the fragment was 
evaluated by electrophoretic run on 1% agarose gel. Subsequently 
the chromatin was diluted in a chromatin dilution buffer (0.01% 
SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 
8.1, 167 mM NaCl). Sonicated chromatin was immunoprecipitated 
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with antibodies (4-5 μg of antibody in 40 μl of beads) anti-H4-Ac 
(Millipore 06-866) and (8 g of antibody in 40 l of beads) anti 
RARα (Santa Cruz sc-551), over night at 4° C. The immune 
complexes were collected by incubation with magnetic beads 
(Dynabeads
TM
 M-280 Sheep anti-Rabbit IgG, Invitrogen) for 4 
hours at 4° C and then subjected to 3 different washes: 4 times low 
salt concentration buffer (0.1% SDS, 1% TritonX-100, 2mM 
EDTA, 20mM TrisHCl, pH 8.1, 150mM NaCl); 3 times high salt 
concentration buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 
20mM Tris-HCl, pH 8.1, 500mM NaCl); once Tris / EDTA buffer. 
and finally were eluted with elution buffer (1% SDS, 0.1 M 
NaHCO3) for 30 minutes at 37° C. DNA was reverse cross-linked 
with 0,2 M NaCl and recovered with the phenol / chloroform 
protocol followed by ethanol precipitation.  
The extracted DNA was amplified by Real-Time PCR with LR1 
primers, targeting 105 bp across the TSS1 GDNF; with Forward 
and Reverse RARE primers, which amplify 142 bp across DR5 
RARE on the GDNF promoter; with LR3 primers which amplify 
142 bp in the first GDNF intron, as a negative control. Real-time 
PCR was performed with FluoCycleTMII SYBR Green Mix 
(Euroclone).  
For data analysis the 'the percentage of input' method was used 
(http://www.thermofisher.com/en/en/home/life-science/epigenetics-
noncodingrnaresearch/chromatin-remodeling/chromatin-
immunoprecipitation- chip / chip-analysis.html). 
 
 
 
Primers name sequences 
L1 GAAAAGCCACTGGAGGGCAC 
R1 GCGGAACAGCCGAGAGAGGA 
Forward RARE GTCCTTGCTTAGGTTCGCCA 
Reverse RARE CGTGGGGTAGGCACATACAT 
L3 GAGGTGTAGCCTGGGTGTTC 
R3 TTTGGTTGCTAAACGGCTGC  
 
Table 3: primers used for ChiP assay 
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Human organ cultures 
 
All the experiments were performed on surgical testicular biopsies 
obtained from heart-beating organ donors, from the hospital 
Policlinico Umberto I of Rome. Donors were aged between 19 and 
85 years and for each of them the free and  informed consent of the 
family was obtained. 
The Ethical Committee of the hospital approved the use of  human 
material for our study, according to national guidelines for organ 
donation as issued by the Italian Ministry of Public Health. 
Hanging drop culture was performed as described by Jørgensen 
(Jørgensen et al., 2014). The testicular biopsies were cut into 2 mm
3
 
fragments and then each fragment was placed into a drop of 
medium, positioned on the lid of the plate, containing DMEM 
(Sigma-Aldrich, Milan, Italy) with penicillin (100U/ml)/ 
streptomycin (100 mg/ml) (Sigma-Aldrich, Milan, Italy), insulin 
(25µg/ml) (Sigma-Aldrich, Milan, Italy), apotransferrin (100µg/ml) 
(Sigma-Aldrich, Milan, Italy), sodium selenite (30nM) (Sigma-
Aldrich, Milan, Italy)  and 0.1% BSA. PBS was added to the bottom 
of the dish to maintain fragments hydration. Tissues were cultured 
at 34° C in 5% CO2 with or without 1 or 10 M RA for 8 hours. At 
the end of the culture fragments were washed in PBS and lysed with 
TRIzol (Sigma-Aldrich, Milan, Italy) for the RNA extraction. For 
all donors each condition was performed in duplicate and the RNA 
was isolated from ten fragments pulled together. 
Statistical analysis 
Statistical analysis was performed using the Sigma Plot 11.0 
program. Quantitative data are shown as the mean ± standard error 
of the mean (SEM) or percentile plots for human data. To define the 
significance of the differences between two groups, data were 
analyzed using a t-test. To compare many groups, data were 
analyzed using a one-way analysis of variance (ANOVA) followed 
by a post hoc Dunn‟s method.  The significance level was fixed at  
= 0.05.   
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